Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

108.07
Delayed Data
As of Aug 23
 +1.25 / +1.17%
Today’s Change
71.63
Today|||52-Week Range
139.79
-0.32%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Jalaa Equities Lp
Director
Sale5/06/201615,000$118.52$1.8M-9.31%
Foehr Matthew W
President & Chief Operating Officer
Sale8/05/201612,500$122.14$1.5M-12.35%
Berkman Charles S
General Counsel, Secretary & Vice President
Sale8/05/201612,084$123.16$1.5M-12.35%
Jalaa Equities Lp
Director
Sale5/05/201610,000$120.21$1.2M-8.60%
Higgins John L
Chief Executive Officer
Sale3/07/201610,277$102.44$1.1M+5.65%
Berkman Charles S
General Counsel, Secretary & Vice President
Buy8/05/201612,084$74.42$899.3K-12.35%
Herman Melanie J
Director-Accounting
Sale11/11/20157,719$101.00$779.6K+10.61%
Berkman Charles S
General Counsel, Secretary & Vice President
Sale8/05/20165,688$123.16$700.5K-12.35%
Foehr Matthew W
President & Chief Operating Officer
Sale3/17/20166,400$96.70$618.9K+11.16%
Kozarich John W
Director
Sale4/06/20165,000$115.00$575.0K-7.85%
Page of 7